NeueHealth, Inc. (NYSE:NEUE) Short Interest Up 33.7% in March

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 12,300 shares, an increase of 33.7% from the February 28th total of 9,200 shares. Based on an average daily volume of 47,300 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.5% of the company's shares are short sold.

Insider Activity at NeueHealth

In other news, CEO George Lawrence Mikan III sold 31,798 shares of the business's stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $233,079.34. Following the transaction, the chief executive officer now owns 146,539 shares in the company, valued at approximately $1,074,130.87. The trade was a 17.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jay Matushak sold 4,448 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total transaction of $29,979.52. Following the sale, the chief financial officer now owns 41,592 shares of the company's stock, valued at approximately $280,330.08. This trade represents a 9.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 110,033 shares of company stock worth $774,560 over the last three months. Company insiders own 64.30% of the company's stock.

Remove Ads

Institutional Trading of NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. Virtu Financial LLC acquired a new stake in NeueHealth, Inc. (NYSE:NEUE - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 10,232 shares of the company's stock, valued at approximately $76,000. Virtu Financial LLC owned 0.12% of NeueHealth as of its most recent filing with the Securities & Exchange Commission. 63.88% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Royal Bank of Canada cut their target price on NeueHealth from $8.00 to $7.00 and set a "sector perform" rating on the stock in a research report on Monday, December 9th.

NeueHealth Stock Performance

Shares of NEUE stock traded down $0.24 during trading hours on Friday, hitting $6.25. 13,471 shares of the company were exchanged, compared to its average volume of 20,075. The company has a 50 day simple moving average of $6.87 and a two-hundred day simple moving average of $6.10. The firm has a market cap of $51.78 million, a P/E ratio of -0.12 and a beta of 0.56. NeueHealth has a fifty-two week low of $3.79 and a fifty-two week high of $7.66.

NeueHealth (NYSE:NEUE - Get Free Report) last posted its quarterly earnings results on Thursday, March 20th. The company reported ($7.41) EPS for the quarter, missing analysts' consensus estimates of ($2.29) by ($5.12). NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%. The company had revenue of $232.64 million during the quarter, compared to analyst estimates of $261.80 million. As a group, sell-side analysts expect that NeueHealth will post -9.13 EPS for the current fiscal year.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.